What's in Labopharm Inc.'s pipeline?

Labopharm Inc. has 10 drugs in our index: 4 marketed, 0 filed, 4 in Phase 3, 0 in Phase 2, 2 in Phase 1.

Which companies overlap with Labopharm Inc.'s portfolio?

Top competitors by shared drug class: University of Pennsylvania, Janssen Korea, Ltd., Korea, Purdue Pharma LP, Tel-Aviv Sourasky Medical Center, University of Puerto Rico.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/labopharm-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-15 · How we verify

Labopharm Inc. — Portfolio Competitive Intelligence Brief

Labopharm Inc. pipeline: 4 marketed, 0 filed, 4 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

4 marketed 0 filed 4 Phase 3 0 Phase 2 2 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Tramadol HCl	Tramadol HCl	marketed	Synthetic opioid analgesic with monoamine reuptake inhibition	Mu opioid receptor; norepinephrine transporter; serotonin transporter	Pain Management
Trazodone HCl	Trazodone HCl	marketed	Serotonin antagonist and reuptake inhibitor (SARI)	Serotonin transporter (SERT); 5-HT2A receptor antagonist	Psychiatry / Neurology
Ultracet®	Ultracet®	marketed	Opioid analgesic combination	Mu-opioid receptor; norepinephrine and serotonin transporters; COX enzymes	Pain Management
Zaldiar®	Zaldiar®	marketed	Opioid analgesic combination	μ-opioid receptor; norepinephrine and serotonin transporters; COX (paracetamol component)	Pain Management
Tramadol Once A Day	Tramadol Once A Day	phase 3	Opioid analgesic	mu-opioid receptor	Pain management
Tramadol OAD	Tramadol OAD	phase 3	Opioid analgesic with norepinephrine-serotonin reuptake inhibition	Mu opioid receptor; norepinephrine transporter; serotonin transporter	Pain Management
Tramadol HCl Twice a day	Tramadol HCl Twice a day	phase 3	Opioid analgesic	mu-opioid receptor	Pain management
Tramadol HCl Contramid® Once A Day	Tramadol HCl Contramid® Once A Day	phase 3	Opioid analgesic	mu-opioid receptor	Pain management

Therapeutic area mix

Pain Management · 4
Pain management · 3
Other · 1
Psychiatry / Neurology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

University of Pennsylvania · 2 shared drug classes
Janssen Korea, Ltd., Korea · 2 shared drug classes
Purdue Pharma LP · 2 shared drug classes
Tel-Aviv Sourasky Medical Center · 2 shared drug classes
University of Puerto Rico · 2 shared drug classes
University of Rochester · 2 shared drug classes
Alza Corporation, DE, USA · 1 shared drug class
Albert Einstein College of Medicine · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Labopharm Inc.:

Cite this brief

Drug Landscape (2026). Labopharm Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/labopharm-inc. Accessed 2026-05-15.